Inhibition of NE with synthetic inhibitors (9) or with the recombinant human elastase inhibitor elafin (10) is effective in preventing and reversing pulmonary hypertension in animal models and promoting regression of pulmonary arterial pathology in human organ cultures (10). Here, ELANE is linked to pulmonary arterial hypertension.